Insider · CIK 0001405288

FOUSE JACQUALYN A

Reports to the SEC for 8 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001405288

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-18	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)A Award	Director	AAward	+15K sh	—	—	14,950
2026-06-18	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Director	MExercise/Conversion	−2,816 sh	—	—	0
2026-06-18	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,816 sh	—	—	154,156
2026-06-18	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Director	AAward	+2,927 sh	—	—	2,927
2026-06-17	MDGLMADRIGAL PHARMACEUTICALS, INC.A Award	Director	AAward	+454 sh	—	—	1,551
2026-06-17	MDGLMADRIGAL PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+766 sh	—	—	766
2026-06-08	INCYINCYTE CORPA Award	Director	AAward	+1,642 sh	—	—	20,968
2026-06-08	INCYINCYTE CORP · Non Qualfied Stock Option (right to buy)A Award	Director	AAward	+6,111 sh	—	—	6,111
2025-06-20	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Director	MExercise/Conversion	−2,120 sh	—	—	0
2025-06-20	MDGLMADRIGAL PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+366 sh	—	—	366
2025-06-20	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,120 sh	—	—	151,340
2025-06-20	MDGLMADRIGAL PHARMACEUTICALS, INC.A Award	Director	AAward	+203 sh	—	—	1,097
2025-06-18	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Director	AAward	+2,816 sh	—	—	2,816
2025-06-18	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)A Award	Director	AAward	+15.8K sh	—	—	15,768
2025-06-10	INCYINCYTE CORPA Award	Director	AAward	+2,518 sh	—	—	19,326
2025-06-10	INCYINCYTE CORP · Non Qualfied Stock Option (right to buy)A Award	Director	AAward	+9,216 sh	—	—	9,216
2025-04-10	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Director	SSale	−7,497 sh	$25.90	−$194K	149,220
2025-04-08	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Director	MExercise/Conversion	−15.9K sh	—	—	0
2025-04-08	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+15.9K sh	—	—	156,717
2025-03-10	MDGLMADRIGAL PHARMACEUTICALS, INC.A Award	Director	AAward	+894 sh	—	—	894
2025-03-10	MDGLMADRIGAL PHARMACEUTICALS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+1,579 sh	—	—	1,579
2024-06-20	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)A Award	Director	AAward	+11.8K sh	—	—	11,774
2024-06-20	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Director	AAward	+2,120 sh	—	—	2,120
2024-06-13	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Director	MExercise/Conversion	−3,388 sh	—	—	0
2024-06-13	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+3,388 sh	—	—	140,784
2024-06-12	INCYINCYTE CORP · Non Qualfied Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,517
2024-06-12	INCYINCYTE CORPA Award	Director	AAward	+2,830 sh	—	—	16,808
2024-04-10	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Director	SSale	−7,791 sh	$27.55	−$215K	137,396
2024-04-08	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Director	MExercise/Conversion	−15.9K sh	—	—	15,933
2024-04-08	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+15.9K sh	—	—	145,187
2024-01-24	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Director	SSale	−10.7K sh	$21.64	−$232K	129,253
2024-01-20	AGIOAGIOS PHARMACEUTICALS, INC. · Performance share unitsM Exercise/Conversion	Director	MExercise/Conversion	−23.9K sh	—	—	0
2024-01-20	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+23.9K sh	—	—	139,975
2024-01-09	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Director	SSale	−8,391 sh	$22.99	−$193K	116,075
2024-01-05	AGIOAGIOS PHARMACEUTICALS, INC. · Performance share unitsM Exercise/Conversion	Director	MExercise/Conversion	−17.5K sh	—	—	0
2024-01-05	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+17.5K sh	—	—	124,466
2023-06-30	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Director	SSale	−10.7K sh	$28.36	−$304K	106,966
2023-06-28	AGIOAGIOS PHARMACEUTICALS, INC. · Performance share unitsM Exercise/Conversion	Director	MExercise/Conversion	−23.9K sh	—	—	23,900
2023-06-28	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+23.9K sh	—	—	117,684
2023-06-14	INCYINCYTE CORP · Non-Qualified Stock Option (right to buy)A Award	Director	AAward	+11.3K sh	—	—	11,294
2023-06-14	INCYINCYTE CORPA Award	Director	AAward	+2,505 sh	—	—	13,978
2023-06-13	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)A Award	Director	AAward	+19K sh	—	—	18,958
2023-06-13	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Director	AAward	+3,388 sh	—	—	3,388
2023-04-12	AGIOAGIOS PHARMACEUTICALS, INC.F Tax Payment	Director	FTax Payment	−4,731 sh	$21.35	−$101K	93,784
2023-04-08	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Director	MExercise/Conversion	−15.9K sh	—	—	31,867
2023-04-08	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+15.9K sh	—	—	98,515
2023-02-16	AGIOAGIOS PHARMACEUTICALS, INC.F Tax Payment	Director	FTax Payment	−3,648 sh	$28.91	−$105K	82,582
2023-02-14	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Director	MExercise/Conversion	−11.3K sh	—	—	0
2023-02-14	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+11.3K sh	—	—	86,230
2022-12-30	INCYINCYTE CORPA Award	Director	AAward	+252 sh	$80.32	+$20.2K	11,473

Recent filings

Accepted (ET)
Jun 234
FOUSE JACQUALYN A0001439222-26-000101
SEC(opens sec.gov)
Jun 184
FOUSE JACQUALYN A0001628280-26-044325
SEC(opens sec.gov)
Jun 104
FOUSE JACQUALYN A0001405288-26-000006
SEC(opens sec.gov)
Jun 244
FOUSE JACQUALYN A0001628280-25-032855
SEC(opens sec.gov)
Jun 234
FOUSE JACQUALYN A0001439222-25-000055
SEC(opens sec.gov)
Jun 124
FOUSE JACQUALYN A0001628280-25-031013
SEC(opens sec.gov)
Apr 104
FOUSE JACQUALYN A0001439222-25-000029
SEC(opens sec.gov)
Mar 124
FOUSE JACQUALYN A0001628280-25-012364
SEC(opens sec.gov)

Companies

Address

C/O AGIOS PHARMACEUTICALS, INC. 88 SIDNEY STREET

CAMBRIDGE, MA, 02139